Fresenius nets FDA breakthrough stamp for dialysis system designed to prevent blood clots

Fresenius Medical Care received a breakthrough device designation from the FDA for a new hemodialysis system that is designed to prevent blood clots internally, without requiring patients to take blood thinning medications.

Sourced through Scoop.it from: www.fiercebiotech.com